However, in our subgroup analysis excluding patients with recent strokes, we confirmed persistently elevated NfL levels (90% in CSF, 50% in serum) in non-stroke PACNS patients, indicating a significant inflammatory contribution to NfL elevation, irrespective of ischemic events. The gene discussed is NEFL; the disease is Stroke.